Karlheinz Gast - Net Worth and Insider Trading

Karlheinz Gast Net Worth

The estimated net worth of Karlheinz Gast is at least $0 dollars as of 2024-05-10. Karlheinz Gast is the Board of Directors of Apontis Pharma AG and owns about 0 shares of Apontis Pharma AG (XTER:APPH) stock worth over $0. Details can be seen in Karlheinz Gast's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karlheinz Gast has not made any transactions after 2023-05-04 and currently still holds the listed stock(s).

Transaction Summary of Karlheinz Gast

To

Karlheinz Gast Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karlheinz Gast owns 1 companies in total, including Apontis Pharma AG (XTER:APPH) .

Click here to see the complete history of Karlheinz Gast’s form 4 insider trades.

Insider Ownership Summary of Karlheinz Gast

Ticker Comapny Transaction Date Type of Owner
XTER:APPH Apontis Pharma AG 2023-05-04 Board of Directors

Karlheinz Gast Latest Holdings Summary

Karlheinz Gast currently owns a total of 1 stock. Karlheinz Gast owns 0 shares of Apontis Pharma AG (XTER:APPH) as of May 4, 2023, with a value of $0.

Latest Holdings of Karlheinz Gast

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XTER:APPH Apontis Pharma AG 2023-05-04 0 8.72 0

Holding Weightings of Karlheinz Gast


Karlheinz Gast Form 4 Trading Tracker

According to the SEC Form 4 filings, Karlheinz Gast has made a total of 1 transactions in Apontis Pharma AG (XTER:APPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Apontis Pharma AG is the acquisition of 5,000 shares on May 4, 2023, which cost Karlheinz Gast around $36,625.

Insider Trading History of Karlheinz Gast

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karlheinz Gast Trading Performance

GuruFocus tracks the stock performance after each of Karlheinz Gast's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karlheinz Gast is -18.55%. GuruFocus also compares Karlheinz Gast's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karlheinz Gast within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Karlheinz Gast's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Karlheinz Gast

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.06
Relative Return to S&P 500(%) 18.61

Karlheinz Gast Ownership Network

Ownership Network List of Karlheinz Gast

No Data

Ownership Network Relation of Karlheinz Gast


Karlheinz Gast Owned Company Details

What does Apontis Pharma AG do?

Who are the key executives at Apontis Pharma AG?

Karlheinz Gast is the Board of Directors of Apontis Pharma AG. Other key executives at Apontis Pharma AG include and Board of Directors Thomas Milz .

Apontis Pharma AG (XTER:APPH) Insider Trades Summary

Over the past 18 months, Karlheinz Gast made 1 insider transaction in Apontis Pharma AG (XTER:APPH) with a net purchase of 5,000. Other recent insider transactions involving Apontis Pharma AG (XTER:APPH) include a net purchase of 2,000 shares made by Thomas Milz ,

In summary, during the past 3 months, insiders sold 0 shares of Apontis Pharma AG (XTER:APPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apontis Pharma AG (XTER:APPH) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.

Apontis Pharma AG (XTER:APPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apontis Pharma AG Insider Transactions

No Available Data

Karlheinz Gast Mailing Address

Above is the net worth, insider trading, and ownership report for Karlheinz Gast. Currently GuruFocus does not have mailing address information for Karlheinz Gast.

Discussions on Karlheinz Gast

No discussions yet.